Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 297

1.

Epidemiological overview of metastatic ovarian carcinoma: long-term experience of TOTSG database.

Kajiyama H, Suzuki S, Utsumi F, Nishino K, Niimi K, Mizuno M, Yoshikawa N, Kawai M, Oguchi H, Mizuno K, Yamamuro O, Shibata K, Nagasaka T, Kikkawa F.

Nagoya J Med Sci. 2019 May;81(2):193-198. doi: 10.18999/nagjms.81.2.193.

2.

Long-term oncologic outcome and its prognostic indicators in reproductive-age women with ovarian clear-cell carcinoma.

Kajiyama H, Suzuki S, Yoshikawa N, Niimi K, Kawai M, Shibata K, Kikkawa F.

Arch Gynecol Obstet. 2019 Jun 4. doi: 10.1007/s00404-019-05203-y. [Epub ahead of print]

PMID:
31165243
3.

Osteomyelitis due to methicillin-resistant Staphylococcus aureus successfully treated by an oral combination of minocycline and trimethoprim-sulfamethoxazole.

Sato K, Yazawa H, Ikuma D, Maruyama T, Kajiyama H, Mimura T.

SAGE Open Med Case Rep. 2019 Apr 9;7:2050313X19841465. doi: 10.1177/2050313X19841465. eCollection 2019.

4.

Estrogen producing ovarian fibrosarcoma: A case report.

Miura M, Suzuki S, Shibata K, Kajiyama H, Kikkawa F.

Nagoya J Med Sci. 2019 Feb;81(1):171-176. doi: 10.18999/nagjms.81.1.171.

5.

Comparison of long-term oncologic outcomes between metastatic ovarian carcinoma originating from gastrointestinal organs and advanced mucinous ovarian carcinoma.

Kajiyama H, Suzuki S, Utsumi F, Yoshikawa N, Nishino K, Ikeda Y, Niimi K, Yamamoto E, Kawai M, Shibata K, Nagasaka T, Kikkawa F.

Int J Clin Oncol. 2019 Aug;24(8):950-956. doi: 10.1007/s10147-019-01438-6. Epub 2019 Apr 2.

PMID:
30941534
6.

Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary.

Kajiyama H, Suzuki S, Yoshikawa N, Kawai M, Shibata K, Nagasaka T, Kikkawa F.

Int J Gynecol Cancer. 2019 Jun;29(5):910-915. doi: 10.1136/ijgc-2018-000142. Epub 2019 Mar 5.

PMID:
30839284
7.

Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer.

Kajiyama H, Suzuki S, Niimi K, Tamauchi S, Kawai M, Nagasaka T, Shibata K, Kikkawa F.

Int J Clin Oncol. 2019 Jul;24(7):857-862. doi: 10.1007/s10147-019-01416-y. Epub 2019 Feb 15.

PMID:
30771039
8.

Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis.

Kitagawa A, Tsuboi N, Yokoe Y, Katsuno T, Ikeuchi H, Kajiyama H, Endo N, Sawa Y, Suwa J, Sugiyama Y, Hachiya A, Mimura T, Hiromura K, Maruyama S.

Kidney Int. 2019 Mar;95(3):680-692. doi: 10.1016/j.kint.2018.10.025. Epub 2019 Jan 31.

PMID:
30712924
9.

Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.

Kajiyama H, Suzuki S, Yoshikawa N, Kawai M, Nagasaka T, Kikkawa F.

Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:131-136. doi: 10.1016/j.ejogrb.2019.01.009. Epub 2019 Jan 17.

PMID:
30685661
10.

Does postoperative prophylactic irradiation of para-aortic lymph nodes reduce the risk of recurrence in uterine cervical cancer with positive pelvic lymph nodes?

Yoshida K, Kajiyama H, Yoshihara M, Ikeda Y, Yoshikawa N, Nishino K, Utsumi F, Niimi K, Suzuki S, Kikkawa F.

Int J Clin Oncol. 2019 May;24(5):567-574. doi: 10.1007/s10147-018-1376-2. Epub 2019 Jan 5.

PMID:
30612268
11.

Endometriosis and cancer.

Kajiyama H, Suzuki S, Yoshihara M, Tamauchi S, Yoshikawa N, Niimi K, Shibata K, Kikkawa F.

Free Radic Biol Med. 2019 Mar;133:186-192. doi: 10.1016/j.freeradbiomed.2018.12.015. Epub 2018 Dec 15. Review.

PMID:
30562557
12.

Non-thermal plasma-activated medium modified metabolomic profiles in the glycolysis of U251SP glioblastoma.

Kurake N, Ishikawa K, Tanaka H, Hashizume H, Nakamura K, Kajiyama H, Toyokuni S, Kikkawa F, Mizuno M, Hori M.

Arch Biochem Biophys. 2019 Feb 15;662:83-92. doi: 10.1016/j.abb.2018.12.001. Epub 2018 Dec 5.

PMID:
30528778
13.

PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination.

Peng Y, Kajiyama H, Yuan H, Nakamura K, Yoshihara M, Yokoi A, Fujikake K, Yasui H, Yoshikawa N, Suzuki S, Senga T, Shibata K, Kikkawa F.

Cancer Lett. 2019 Feb 1;442:181-192. doi: 10.1016/j.canlet.2018.10.027. Epub 2018 Oct 26.

PMID:
30429105
14.

Molecular mechanisms of non-thermal plasma-induced effects in cancer cells.

Tanaka H, Mizuno M, Ishikawa K, Toyokuni S, Kajiyama H, Kikkawa F, Hori M.

Biol Chem. 2018 Dec 19;400(1):87-91. doi: 10.1515/hsz-2018-0199. Review.

PMID:
30291778
15.

Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells.

Koya Y, Liu W, Yamakita Y, Senga T, Shibata K, Yamashita M, Nawa A, Kikkawa F, Kajiyama H.

Oncotarget. 2018 Aug 24;9(66):32609-32623. doi: 10.18632/oncotarget.25975. eCollection 2018 Aug 24.

16.

Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study.

Tamauchi S, Kajiyama H, Yoshihara M, Ikeda Y, Yoshikawa N, Nishino K, Utsumi F, Niimi K, Suzuki S, Kikkawa F.

Am J Obstet Gynecol. 2018 Oct;219(4):385.e1-385.e7. doi: 10.1016/j.ajog.2018.07.021. Epub 2018 Aug 4.

17.

Fertility-sparing surgery of malignant transformation arising from mature cystic teratoma of the ovary.

Yoshikawa N, Teshigawara T, Ikeda Y, Nishino K, Sakata J, Utsumi F, Niimi K, Sekiya R, Suzuki S, Kawai M, Shibata K, Kikkawa F, Kajiyama H.

Oncotarget. 2018 Jun 8;9(44):27564-27573. doi: 10.18632/oncotarget.25548. eCollection 2018 Jun 8.

18.

The upregulated expression of vascular endothelial growth factor in surgically treated patients with recurrent/radioresistant cervical cancer of the uterus.

Yoshida K, Suzuki S, Sakata J, Utsumi F, Niimi K, Yoshikawa N, Nishino K, Shibata K, Kikkawa F, Kajiyama H.

Oncol Lett. 2018 Jul;16(1):515-521. doi: 10.3892/ol.2018.8610. Epub 2018 May 2.

19.

Dengue fever during pregnancy.

Tien Dat T, Kotani T, Yamamoto E, Shibata K, Moriyama Y, Tsuda H, Yamashita M, Kajiyama H, Duc Thien Minh D, Quang Thanh L, Kikkawa F.

Nagoya J Med Sci. 2018 May;80(2):241-247. doi: 10.18999/nagjms.80.2.241.

20.

Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.

Liu W, Kajiyama H, Shibata K, Koya Y, Senga T, Kikkawa F.

Oncol Lett. 2018 Jun;15(6):9406-9412. doi: 10.3892/ol.2018.8493. Epub 2018 Apr 13.

21.

KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear‑cell carcinoma cells.

Kawai Y, Shibata K, Sakata J, Suzuki S, Utsumi F, Niimi K, Sekiya R, Senga T, Kikkawa F, Kajiyama H.

Oncol Rep. 2018 Jul;40(1):195-205. doi: 10.3892/or.2018.6401. Epub 2018 Apr 25.

22.

Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model.

Ohara Y, Chew SH, Misawa N, Wang S, Somiya D, Nakamura K, Kajiyama H, Kikkawa F, Tsuyuki Y, Jiang L, Yamashita K, Sekido Y, Lipson KE, Toyokuni S.

Oncotarget. 2018 Apr 6;9(26):18494-18509. doi: 10.18632/oncotarget.24892. eCollection 2018 Apr 6.

23.

Discovery of novel 2-[(4-hydroxy-6-oxo-2,3-dihydro-1H-pyridine-5-carbonyl)amino]acetic acid derivatives as HIF prolyl hydroxylase inhibitors for treatment of renal anemia.

Hamada M, Takayama T, Shibata T, Hiratate A, Takahashi M, Yashiro M, Takayama N, Okumura-Kitajima L, Koretsune H, Kajiyama H, Naruse T, Kato S, Takano H, Kakinuma H.

Bioorg Med Chem Lett. 2018 Jun 1;28(10):1725-1730. doi: 10.1016/j.bmcl.2018.04.039. Epub 2018 Apr 16.

PMID:
29681433
24.

Secondary cytoreductive surgery potentially improves the oncological outcomes of patients with recurrent uterine sarcomas.

Nakamura K, Kajiyama H, Utsumi F, Suzuki S, Niimi K, Sekiya R, Sakata J, Yamamoto E, Shibata K, Kikkawa F.

Mol Clin Oncol. 2018 Mar;8(3):499-503. doi: 10.3892/mco.2018.1560. Epub 2018 Jan 19.

25.

The possible existence of occult metastasis in patients with ovarian clear-cell carcinoma who underwent complete resection without any residual tumours.

Kajiyama H, Suzuki S, Yoshihara M, Nishino K, Yoshikawa N, Utsumi F, Niimi K, Mizuno M, Kawai M, Oguchi H, Mizuno K, Yamamuro O, Nagasaka T, Shibata K, Kikkawa F.

Oncotarget. 2018 Jan 4;9(5):6298-6307. doi: 10.18632/oncotarget.23921. eCollection 2018 Jan 19.

26.

A post-recurrence survival-predicting indicator for cervical cancer from the analysis of 165 patients who developed recurrence.

Yoshida K, Kajiyama H, Utsumi F, Niimi K, Sakata J, Suzuki S, Shibata K, Kikkawa F.

Mol Clin Oncol. 2018 Feb;8(2):281-285. doi: 10.3892/mco.2017.1530. Epub 2017 Dec 8.

27.

Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis.

Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovský J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K.

Ann Rheum Dis. 2018 Apr;77(4):602-611. doi: 10.1136/annrheumdis-2017-212149. Epub 2018 Jan 13.

PMID:
29331962
28.

Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells.

Sakata J, Utsumi F, Suzuki S, Niimi K, Yamamoto E, Shibata K, Senga T, Kikkawa F, Kajiyama H.

Oncotarget. 2017 Aug 10;8(59):99482-99494. doi: 10.18632/oncotarget.20107. eCollection 2017 Nov 21.

29.

Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.

Teshigawara T, Mizuno M, Ishii T, Kitajima Y, Utsumi F, Sakata J, Kajiyama H, Shibata K, Ishizuka M, Kikkawa F.

Photodiagnosis Photodyn Ther. 2018 Mar;21:121-127. doi: 10.1016/j.pdpdt.2017.11.013. Epub 2017 Nov 28.

PMID:
29196245
30.

A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer.

Fujikake K, Kajiyama H, Yoshihara M, Nishino K, Yoshikawa N, Utsumi F, Suzuki S, Niimi K, Sakata J, Mitsui H, Shibata K, Senga T, Kikkawa F.

Oncol Rep. 2018 Jan;39(1):193-200. doi: 10.3892/or.2017.6104. Epub 2017 Nov 20.

PMID:
29192324
31.

A combination of circulating miRNAs for the early detection of ovarian cancer.

Yokoi A, Yoshioka Y, Hirakawa A, Yamamoto Y, Ishikawa M, Ikeda SI, Kato T, Niimi K, Kajiyama H, Kikkawa F, Ochiya T.

Oncotarget. 2017 Sep 6;8(52):89811-89823. doi: 10.18632/oncotarget.20688. eCollection 2017 Oct 27.

32.

Efficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer.

Tamauchi S, Kajiyama H, Utsumi F, Suzuki S, Niimi K, Sakata J, Mizuno M, Shibata K, Kikkawa F.

J Obstet Gynaecol Res. 2018 Jan;44(1):151-156. doi: 10.1111/jog.13473. Epub 2017 Nov 9.

PMID:
29121428
33.

The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis.

Ikuma D, Hiromura K, Kajiyama H, Suwa J, Ikeuchi H, Sakairi T, Kaneko Y, Maeshima A, Kurosawa H, Hirayama Y, Yokota K, Araki Y, Sato K, Asanuma YF, Akiyama Y, Hara M, Nojima Y, Mimura T.

Lupus. 2018 Mar;27(3):484-493. doi: 10.1177/0961203317734918. Epub 2017 Oct 19.

PMID:
29050536
34.

Association of serum asymmetric dimethylarginine, homocysteine, and l-arginine concentrations during early pregnancy with hypertensive disorders of pregnancy.

Maruta E, Wang J, Kotani T, Tsuda H, Nakano T, Imai K, Sumigama S, Niwa Y, Mitsui T, Yoshida S, Yamashita M, Nawa A, Tamakoshi K, Kajiyama H, Kikkawa F.

Clin Chim Acta. 2017 Dec;475:70-77. doi: 10.1016/j.cca.2017.10.007. Epub 2017 Oct 10.

PMID:
29024618
35.

Impact of positive ZEB1 expression in patients with epithelial ovarian carcinoma as an oncologic outcome-predicting indicator.

Sakata J, Kajiyama H, Suzuki S, Utsumi F, Niimi K, Sekiya R, Shibata K, Senga T, Kikkawa F.

Oncol Lett. 2017 Oct;14(4):4287-4293. doi: 10.3892/ol.2017.6658. Epub 2017 Jul 24.

36.

Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells.

Nakamura K, Peng Y, Utsumi F, Tanaka H, Mizuno M, Toyokuni S, Hori M, Kikkawa F, Kajiyama H.

Sci Rep. 2017 Jul 20;7(1):6085. doi: 10.1038/s41598-017-05620-6.

37.

Establishment and characterization of cell lines derived from complete hydatidiform mole.

Yamamoto E, Niimi K, Kiyono T, Yamamoto T, Nishino K, Nakamura K, Kotani T, Kajiyama H, Shibata K, Kikkawa F.

Int J Mol Med. 2017 Sep;40(3):614-622. doi: 10.3892/ijmm.2017.3067. Epub 2017 Jul 14.

38.

Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine cervical cancer.

Miyauchi R, Itoh Y, Kawamura M, Hirakawa A, Shibata K, Kajiyama H, Nakahara R, Kubota S, Ito J, Okada T, Kikkawa F, Naganawa S.

Nagoya J Med Sci. 2017 Feb;79(2):211-220. doi: 10.18999/nagjms.79.2.211.

39.

Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.

Yokoi A, Yoshioka Y, Yamamoto Y, Ishikawa M, Ikeda SI, Kato T, Kiyono T, Takeshita F, Kajiyama H, Kikkawa F, Ochiya T.

Nat Commun. 2017 Mar 6;8:14470. doi: 10.1038/ncomms14470.

40.

c-Rel Promotes Invasion of Choriocarcinoma Cells via PI3K/AKT Signaling.

Sekiya Y, Yamamoto E, Niimi K, Nishino K, Nakamura K, Kotani T, Kajiyama H, Shibata K, Kikkawa F.

Oncology. 2017;92(5):299-310. doi: 10.1159/000458529. Epub 2017 Mar 4.

PMID:
28259870
41.

Prognostic Factors Associated with Preoperative Clinicophysiological Outcomes of Distal Cholangiocarcinoma.

Suzuki S, Kajiyama H, Shimoda M, Shimazaki J, Koike N, Harada N.

Dig Surg. 2017;34(6):476-482. doi: 10.1159/000456082. Epub 2017 Feb 7.

PMID:
28166534
42.

Future perspective of strategic non-thermal plasma therapy for cancer treatment.

Kajiyama H, Utsumi F, Nakamura K, Tanaka H, Toyokuni S, Hori M, Kikkawa F.

J Clin Biochem Nutr. 2017 Jan;60(1):33-38. doi: 10.3164/jcbn.16-65. Epub 2016 Dec 17. Review.

43.

Clinical significance and predicting indicators of post-cancer-treatment survival in terminally ill patients with ovarian cancer.

Utsumi F, Kajiyama H, Niimi K, Sekiya R, Sakata J, Suzuki S, Shibata K, Mizuno M, Kikkawa F.

J Obstet Gynaecol Res. 2017 Feb;43(2):365-370. doi: 10.1111/jog.13219.

PMID:
28150408
44.

Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells.

Koya Y, Kajiyama H, Liu W, Shibata K, Senga T, Kikkawa F.

J Vis Exp. 2016 Dec 9;(118). doi: 10.3791/54353.

45.

Intraperitoneal Administration of Plasma-Activated Medium: Proposal of a Novel Treatment Option for Peritoneal Metastasis From Gastric Cancer.

Takeda S, Yamada S, Hattori N, Nakamura K, Tanaka H, Kajiyama H, Kanda M, Kobayashi D, Tanaka C, Fujii T, Fujiwara M, Mizuno M, Hori M, Kodera Y.

Ann Surg Oncol. 2017 May;24(5):1188-1194. doi: 10.1245/s10434-016-5759-1. Epub 2017 Jan 5.

PMID:
28058557
46.

Clinical characteristics of primary peritoneal carcinoma patients: a single-institution experience involving 8 patients.

Hattori S, Kajiyama H, Fuji U, Furui Y, Ishibashi Y, Hattori Y, Takahashi N, Kikkawa F, Misawa T.

Nagoya J Med Sci. 2016 Dec;78(4):407-414. doi: 10.18999/nagjms.78.4.407.

47.

Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma.

Suzuki S, Sakata J, Utsumi F, Sekiya R, Kajiyama H, Shibata K, Kikkawa F, Nakatsura T.

Oncoimmunology. 2016 Sep 30;5(11):e1238542. doi: 10.1080/2162402X.2016.1238542. eCollection 2016.

48.

Heterotopic Ossification in Rectal Carcinoma: Report of a Case and Review of the Literature.

Shimazaki J, Takemura A, Nishida K, Kajiyama H, Shimoda M, Suzuki S.

Case Rep Oncol. 2016 Nov 8;9(3):698-704. eCollection 2016 Sep-Dec.

49.

Non-thermal atmospheric pressure plasma activates lactate in Ringer's solution for anti-tumor effects.

Tanaka H, Nakamura K, Mizuno M, Ishikawa K, Takeda K, Kajiyama H, Utsumi F, Kikkawa F, Hori M.

Sci Rep. 2016 Nov 8;6:36282. doi: 10.1038/srep36282.

50.

Secretoglobin Superfamily Protein SCGB3A2 Alleviates House Dust Mite-Induced Allergic Airway Inflammation in Mice.

Yoneda M, Xu L, Kajiyama H, Kawabe S, Paiz J, Ward JM, Kimura S.

Int Arch Allergy Immunol. 2016;171(1):36-44. Epub 2016 Nov 8.

Supplemental Content

Loading ...
Support Center